Literature DB >> 8019245

Aminophylline in the hospital treatment of children with acute asthma.

S A McKenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8019245      PMCID： PMC2540379          DOI： 10.1136/bmj.308.6941.1384

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Lack of adverse cardiac effects of combined treatment with theophylline and albuterol in asthmatic children.

Authors:  V Bastianon; A Di Fazio; V Colloridi; M C Marzano; A Ferrucci; S Pucci; L Bernardini; F Coletta; N Sorbara; L Businco
Journal:  Ann Allergy       Date:  1990-09

2.  Double-blind trial of aminophylline in status asthmaticus.

Authors:  W E Pierson; C W Bierman; S J Stamm; P P Van Arsdel
Journal:  Pediatrics       Date:  1971-10       Impact factor: 7.124

3.  Efficacy of intravenously administered theophylline in children hospitalized with severe asthma.

Authors:  E Carter; M Cruz; S Chesrown; G Shieh; K Reilly; L Hendeles
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

4.  Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus.

Authors:  M Singh; L Kumar
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

5.  Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations.

Authors:  R E Strauss; D L Wertheim; V R Bonagura; D J Valacer
Journal:  Pediatrics       Date:  1994-02       Impact factor: 7.124

6.  Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid.

Authors:  G A DiGiulio; C M Kercsmar; S E Krug; S E Alpert; C M Marx
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406
  6 in total
  1 in total

1.  Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial.

Authors:  G Roberts; D Newsom; K Gomez; A Raffles; S Saglani; J Begent; P Lachman; K Sloper; R Buchdahl; A Habel
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.